{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:52:36Z","timestamp":1791406356586,"version":"4.3.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11060-026-05801-2","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:26:24Z","timestamp":1789399584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Brain dose burden is associated with treatment-related lymphopenia in IDH-wildtype glioblastoma: dosimetric determinants and prognostic impact"],"prefix":"10.1007","volume":"179","author":[{"given":"Paolo","family":"Tini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Donnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Pastina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Carfagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Vannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Didona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Vanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Banci Buonamici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"5801_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"5801_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"5801_CR3","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME, Diserens AC, Gorlia T et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997\u20131003. https:\/\/doi.org\/10.1056\/NEJMoa043331","journal-title":"N Engl J Med"},{"key":"5801_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/07357907.2012.762780","volume":"31","author":"S Yovino","year":"2013","unstructured":"Yovino S, Kleinberg L, Grossman SA, Narayanan M, Ford E (2013) The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells. Cancer Invest 31:140\u2013144. https:\/\/doi.org\/10.3109\/07357907.2012.762780","journal-title":"Cancer Invest"},{"key":"5801_CR5","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.6004\/jnccn.2015.0151","volume":"13","author":"SA Grossman","year":"2015","unstructured":"Grossman SA, Ellsworth S, Campian J et al (2015) Survival in patients with severe lymphopenia following treatment with radiation and chemotherapy for newly diagnosed solid tumors. J Natl Compr Canc Netw 13:1225\u20131231. https:\/\/doi.org\/10.6004\/jnccn.2015.0151","journal-title":"J Natl Compr Canc Netw"},{"key":"5801_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11060-015-2037-1","volume":"127","author":"JS Mendez","year":"2016","unstructured":"Mendez JS, Govindan A, Leong J et al (2016) Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma. J Neurooncol 127:329\u2013335. https:\/\/doi.org\/10.1007\/s11060-015-2037-1","journal-title":"J Neurooncol"},{"key":"5801_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11060-017-2668-5","volume":"136","author":"AJ Lin","year":"2018","unstructured":"Lin AJ, Campian JL, Hui C et al (2018) Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy. J Neurooncol 136:403\u2013411. https:\/\/doi.org\/10.1007\/s11060-017-2668-5","journal-title":"J Neurooncol"},{"key":"5801_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11060-019-03167-2","volume":"143","author":"WJ Kim","year":"2019","unstructured":"Kim WJ, Dho YS, Ock CY et al (2019) Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma. J Neurooncol 143:321\u2013328. https:\/\/doi.org\/10.1007\/s11060-019-03167-2","journal-title":"J Neurooncol"},{"key":"5801_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jocn.2019.11.017","volume":"71","author":"S Ahn","year":"2020","unstructured":"Ahn S, Park JS, Jang J et al (2020) The association between total lymphocyte count after concomitant chemoradiation and overall survival in patients with newly diagnosed glioblastoma. J Clin Neurosci 71:21\u201325. https:\/\/doi.org\/10.1016\/j.jocn.2019.11.017","journal-title":"J Clin Neurosci"},{"key":"5801_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13014-023-02393-3","volume":"19","author":"AM Saeed","year":"2024","unstructured":"Saeed AM, Bentzen SM, Ahmad H et al (2024) Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients. Radiat Oncol 19:36. https:\/\/doi.org\/10.1186\/s13014-023-02393-3","journal-title":"Radiat Oncol"},{"key":"5801_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.14791\/btrt.2020.8.e12","volume":"8","author":"C Lee","year":"2020","unstructured":"Lee C, Ahn S, Park JS et al (2020) Effect of cumulative dexamethasone dose during concomitant chemoradiation on lymphopenia in patients with newly diagnosed glioblastoma. Brain Tumor Res Treat 8:71\u201376. https:\/\/doi.org\/10.14791\/btrt.2020.8.e12","journal-title":"Brain Tumor Res Treat"},{"key":"5801_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ijrobp.2018.01.069","volume":"101","author":"S Rudra","year":"2018","unstructured":"Rudra S, Hui C, Rao YJ et al (2018) Effect of radiation treatment volume reduction on lymphopenia in patients receiving chemoradiotherapy for glioblastoma. Int J Radiat Oncol Biol Phys 101:217\u2013225. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.01.069","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5801_CR13","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/neuonc\/noaa182","volume":"23","author":"R Mohan","year":"2021","unstructured":"Mohan R, Liu AY, Brown PD et al (2021) Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons versus photons. Neuro Oncol 23:284\u2013294. https:\/\/doi.org\/10.1093\/neuonc\/noaa182","journal-title":"Neuro Oncol"},{"key":"5801_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13014-019-1256-6","volume":"14","author":"HK Byun","year":"2019","unstructured":"Byun HK, Kim N, Yoon HI et al (2019) Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era. Radiat Oncol 14:51. https:\/\/doi.org\/10.1186\/s13014-019-1256-6","journal-title":"Radiat Oncol"},{"key":"5801_CR15","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1002\/cam4.2159","volume":"8","author":"LL Ye","year":"2019","unstructured":"Ye LL, Fan XW, Hu CS et al (2019) Dosimetry of the brain and hypothalamus predicting acute lymphopenia and the survival of glioma patients with postoperative radiotherapy. Cancer Med 8:2759\u20132768. https:\/\/doi.org\/10.1002\/cam4.2159","journal-title":"Cancer Med"},{"key":"5801_CR16","doi-asserted-by":"publisher","first-page":"100799","DOI":"10.1016\/j.ctro.2024.100799","volume":"47","author":"N Kim","year":"2024","unstructured":"Kim N, Lee J, Shin H et al (2024) Nomogram for radiation-induced lymphopenia in patients receiving intensity-modulated radiotherapy-based chemoradiation therapy for newly diagnosed glioblastoma: a multi-institutional study. Clin Transl Radiat Oncol 47:100799. https:\/\/doi.org\/10.1016\/j.ctro.2024.100799","journal-title":"Clin Transl Radiat Oncol"},{"key":"5801_CR17","doi-asserted-by":"publisher","unstructured":"Das A et al (2024) Impact of intensity-modulated proton therapy in reducing radiation-induced lymphopenia in glioma patients. Neurooncol Adv 6:vdae088. https:\/\/doi.org\/10.1093\/noajnl\/vdae088","DOI":"10.1093\/noajnl\/vdae088"},{"key":"5801_CR18","doi-asserted-by":"publisher","first-page":"109663","DOI":"10.1016\/j.radonc.2023.109663","volume":"184","author":"M Niyazi","year":"2023","unstructured":"Niyazi M, Andratschke N, Bendszus M, Chalmers AJ et al (2023) ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma. Radiother Oncol 184:109663. https:\/\/doi.org\/10.1016\/j.radonc.2023.109663 Epub 2023 Apr 13. PMID: 37059335","journal-title":"Radiother Oncol"},{"key":"5801_CR19","unstructured":"National Cancer Institute (2017) Common Terminology Criteria for Adverse Events (CTCAE), Version 5.0. US Department of Health and Human Services"},{"key":"5801_CR20","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1200\/JCO.23.01059","volume":"41","author":"PY Wen","year":"2023","unstructured":"Wen PY, van den Bent M, Youssef G et al (2023) RANO 2.0: update to the Response Assessment in Neuro-Oncology criteria for high- and low-grade gliomas in adults. J Clin Oncol 41:5187\u20135199. https:\/\/doi.org\/10.1200\/JCO.23.01059","journal-title":"J Clin Oncol"},{"key":"5801_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4149\/neo_2025_250730N330","volume":"72","author":"L Hnidakova","year":"2025","unstructured":"Hnidakova L, Selingerova I, Pospisil P et al (2025) Lymphopenia in glioblastoma and its association with brain vessel irradiation: pilot retrospective evaluation of dose-volume parameters. Neoplasma 72:371\u2013378. https:\/\/doi.org\/10.4149\/neo_2025_250730N330","journal-title":"Neoplasma"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05801-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05801-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05801-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:03:30Z","timestamp":1791403410000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05801-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5801"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05801-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-10815745\/v1","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"25 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Azienda Ospedaliero-Universitaria Senese, Area Vasta Sud-Est (protocol code GLIOMARKERSOBS_2025-1; approval date 6 May 2025).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"<b>Consent to participate<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"81"}}